Drug Side Effects
Search
EMBRYONAL RHABDOMYOSARCOMA
EMBRYONAL RHABDOMYOSARCOMA
was reported 52 times
EMBRYONAL RHABDOMYOSARCOMA is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Actinomycin [EPC]
5
0.0023
1
CD52-directed Cytolytic Antibody [EPC]
10
0.0005
2
Recombinant Human Growth Hormone [EPC]
2
0.0001
3
Thrombopoietin Receptor Agonist [EPC]
1
0.0001
4
Antimetabolite Immunosuppressant [EPC]
1
0.0000
5
Alkylating Drug [EPC]
10
0.0000
6
Calcineurin Inhibitor Immunosuppressant [EPC]
5
0.0000
7
Microtubule Inhibitor [EPC]
5
0.0000
8
Platinum-based Drug [EPC]
7
0.0000
9
Serotonin-3 Receptor Antagonist [EPC]
3
0.0000
10
Purine Antimetabolite [EPC]
2
0.0000
11
Interleukin-12 Antagonist [EPC]
2
0.0000
12
Interleukin-23 Antagonist [EPC]
2
0.0000
13
Folate Analog Metabolic Inhibitor [EPC]
7
0.0000
14
Acetylcholine Release Inhibitor [EPC]
1
0.0000
15
Aminosalicylate [EPC]
1
0.0000
16
Leukocyte Growth Factor [EPC]
1
0.0000
17
Vitamin D [EPC]
2
0.0000
18
Vitamin B12 [EPC]
2
0.0000
19
Vascular Endothelial Growth Factor Inhibitor [EPC]
1
0.0000
20
Vitamin C [EPC]
2
0.0000
21
Corticosteroid [EPC]
5
0.0000
22
Nucleoside Metabolic Inhibitor [EPC]
1
0.0000
23
Loop Diuretic [EPC]
1
0.0000
24
Tumor Necrosis Factor Blocker [EPC]
2
0.0000
25
Proton Pump Inhibitor [EPC]
1
0.0000